We use cookies to ensure that we give you the best experience on our website Learn more

Home

My documents

Saved research

International Diabetes Federation 2017 Congress

04.12.-08.12.2017 · Abu Dhabi - United Arab Emirates · http://idf.org/congress

BALANCE study: safety and efficacy of Gemigliptin and Rosuvastatin as fixed dose combination therapy

dpp4-inhibitor gemigliptin diabetes type 2

The challenge of childhood type 2 diabetes in United Arab Emirates

Community-based diabetes prevention study for high-risk individuals of type 2 diabetes using web-based system

The program of personalized support in type 2 diabetes on insulin therapy: 9 months follow-up of glycemic control

Mayorov Alexander

Seoul Diabetes Prevention (SDP) pilot study in Korean subjects with prediabetes

Knowledge attitudes and practices relating to diabetes and diabetic retinopathy in Pakistan

D'Esposito Fabrizio

Prevalence and determinants of peripheral neuropathy among urban and rural Bangladeshi type 2 diabetic subjects

peripheral sensory neuropathy diabetes dpn

HD-6277, a novel GPR40 agonist improved glycemic control and GLP-1 secretion in rodent models of insulin resistance

gpr40 agonist hd-6277 glp-1 insulin

Quality of life among TB patients with diabetes and TB patients without diabetes attending TB clinics in Karachi.

Kanpurwala Muhammad Adnan

Improving diabetes self-care and glycemic outcome in Lebanese patients with type 2 diabetes: a culturally tailored study

Sukkarieh-Haraty Ola

Effect of meal replacement therapy on body weight and glycemic control in obese type 2 diabetes adults: Asian experience

meal replacement weight loss

Trial-level comparisons of iGlarLixi versus IDegLira in the LixiLan and DUAL clinical development programmes

Blonde Lawrence

Real-world observational study to evaluate probability of achieving glycaemic control in patients with type 2 diabetes

Network meta-analysis of treatments for type 2 diabetes in patients inadequately controlled on oral anti-diabetics

Network meta-analysis of iGlarLixi, a fixed-ratio combination GLP-1 RA and basal insulin, versus insulin premix

Using machine learning on real-world data to identify features correlating with remaining on basal insulin + GLP-1 RA

Using advanced analytics to evaluate real-world treatment pathways leading to basal insulin plus GLP-1 RA therapy

Using advanced machine learning to predict HbA1c control with basal insulin and glucagon-like peptide-1 receptor agonist

Bioinformatics modelling of baseline characteristics to predict clinical outcomes and responses in the LixiLan-L trial

Efficacy and safety of fixed-ratio combination of GLP-1 RAs plus basal insulin in T2D: a network meta-analysis

Pregnancy glycemic status reflects lifecourse glycemic status of the mother

Ghrelin deficiency is associated with obesity, adipose tissue dysfunction and glucose variability in type 2 diabetes

Klimontov Vadim

type 2 diabetes ghrelin obesity

Diabetes awareness and education program

Nimbabazi Othniel

Integrated care pathways for diabetes: being positivist or realist?

1 2 3 4 5 6 7 8 9 10

Company

Legal

Follow us

© Copyright 2019 Morressier GmbH. All rights reserved.

Home About Contact

Imprint Terms of Service Privacy Policy

© Copyright 2019 Morressier GmbH.
All rights reserved.

Imprint Terms of Service Privacy Policy